MACERICH CO
Company Information
Industry Real Estate Investment Trusts
SIC Code 6798
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation MD
Business Address 401 WILSHIRE BLVD, SANTA MONICA, CA, 90401
Mailing Address 401 WILSHIRE BLVD SUITE 700, SANTA MONICA, CA, 90401
Phone 3103946000
Fiscal Year End 1231
EIN 954448705
Financial Overview
FY2024
$8.57B
Total Assets
$112.45M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 4, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 21, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 8-K Current report of material events | December 8, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 5, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 5, 2025 | View on SEC |
| 8-K Current report of material events | November 4, 2025 | View on SEC |
| 4 Insider stock transaction report | September 25, 2025 | View on SEC |
Material Events
8-K Other December 8, 2025
Medium Impact
- MACERICH CO released a special presentation for investors.
- The presentation updates the financial community on the company's business situation, strategies, and outlook.
Related Companies
Companies in the same industry (SIC: 6798)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.